These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 17915954)

  • 1. Irreversible inhibition of the Mycobacterium tuberculosis beta-lactamase by clavulanate.
    Hugonnet JE; Blanchard JS
    Biochemistry; 2007 Oct; 46(43):11998-2004. PubMed ID: 17915954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can inhibitor-resistant substitutions in the Mycobacterium tuberculosis β-Lactamase BlaC lead to clavulanate resistance?: a biochemical rationale for the use of β-lactam-β-lactamase inhibitor combinations.
    Kurz SG; Wolff KA; Hazra S; Bethel CR; Hujer AM; Smith KM; Xu Y; Tremblay LW; Blanchard JS; Nguyen L; Bonomo RA
    Antimicrob Agents Chemother; 2013 Dec; 57(12):6085-96. PubMed ID: 24060876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Activity of β-Lactams in Combination with β-Lactamase Inhibitors against Multidrug-Resistant Mycobacterium tuberculosis Isolates.
    Zhang D; Wang Y; Lu J; Pang Y
    Antimicrob Agents Chemother; 2016 Jan; 60(1):393-9. PubMed ID: 26525785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meropenem-clavulanate has high in vitro activity against multidrug-resistant Mycobacterium tuberculosis.
    Davies Forsman L; Giske CG; Bruchfeld J; Schön T; Juréen P; Ängeby K
    Int J Mycobacteriol; 2015 Mar; 4 Suppl 1():80-1. PubMed ID: 27128620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the inhibition of CTX-M-9 by beta-lactamase inhibitors and carbapenems.
    Bethel CR; Taracila M; Shyr T; Thomson JM; Distler AM; Hujer KM; Hujer AM; Endimiani A; Papp-Wallace K; Bonnet R; Bonomo RA
    Antimicrob Agents Chemother; 2011 Jul; 55(7):3465-75. PubMed ID: 21555770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meropenem-clavulanate is effective against extensively drug-resistant Mycobacterium tuberculosis.
    Hugonnet JE; Tremblay LW; Boshoff HI; Barry CE; Blanchard JS
    Science; 2009 Feb; 323(5918):1215-8. PubMed ID: 19251630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of
    Nantongo M; Nguyen DC; Bethel CR; Taracila MA; Li Q; Dousa KM; Shin E; Kurz SG; Nguyen L; Kreiswirth BN; Boom WH; Plummer MS; Bonomo RA
    ACS Infect Dis; 2024 May; 10(5):1767-1779. PubMed ID: 38619138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrolysis of clavulanate by Mycobacterium tuberculosis β-lactamase BlaC harboring a canonical SDN motif.
    Soroka D; Li de la Sierra-Gallay I; Dubée V; Triboulet S; van Tilbeurgh H; Compain F; Ballell L; Barros D; Mainardi JL; Hugonnet JE; Arthur M
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5714-20. PubMed ID: 26149997
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New Conformations of Acylation Adducts of Inhibitors of β-Lactamase from Mycobacterium tuberculosis.
    Tassoni R; Blok A; Pannu NS; Ubbink M
    Biochemistry; 2019 Feb; 58(7):997-1009. PubMed ID: 30632739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combinatorial active-site variants confer sustained clavulanate resistance in BlaC β-lactamase from Mycobacterium tuberculosis.
    Egesborg P; Carlettini H; Volpato JP; Doucet N
    Protein Sci; 2015 Apr; 24(4):534-44. PubMed ID: 25492589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure of the covalent adduct formed between Mycobacterium tuberculosis beta-lactamase and clavulanate.
    Tremblay LW; Hugonnet JE; Blanchard JS
    Biochemistry; 2008 May; 47(19):5312-6. PubMed ID: 18422342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Shi J; Zheng DW; Ma XG; Su RY; Zhu YK; Wang SH; Chang WJ; Sun GQ; Sun DY
    Zhonghua Jie He He Hu Xi Za Zhi; 2023 Aug; 46(8):797-805. PubMed ID: 37536990
    [No Abstract]   [Full Text] [Related]  

  • 13. Paradoxical Hypersusceptibility of Drug-resistant Mycobacteriumtuberculosis to β-lactam Antibiotics.
    Cohen KA; El-Hay T; Wyres KL; Weissbrod O; Munsamy V; Yanover C; Aharonov R; Shaham O; Conway TC; Goldschmidt Y; Bishai WR; Pym AS
    EBioMedicine; 2016 Jul; 9():170-179. PubMed ID: 27333036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of broad-spectrum Mycobacterium abscessus class A β-lactamase.
    Soroka D; Dubée V; Soulier-Escrihuela O; Cuinet G; Hugonnet JE; Gutmann L; Mainardi JL; Arthur M
    J Antimicrob Chemother; 2014 Mar; 69(3):691-6. PubMed ID: 24132992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routes of Synthesis of Carbapenems for Optimizing Both the Inactivation of L,D-Transpeptidase LdtMt1 of Mycobacterium tuberculosis and the Stability toward Hydrolysis by β-Lactamase BlaC.
    Iannazzo L; Soroka D; Triboulet S; Fonvielle M; Compain F; Dubée V; Mainardi JL; Hugonnet JE; Braud E; Arthur M; Etheve-Quelquejeu M
    J Med Chem; 2016 Apr; 59(7):3427-38. PubMed ID: 26937999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro cross-linking of Mycobacterium tuberculosis peptidoglycan by L,D-transpeptidases and inactivation of these enzymes by carbapenems.
    Cordillot M; Dubée V; Triboulet S; Dubost L; Marie A; Hugonnet JE; Arthur M; Mainardi JL
    Antimicrob Agents Chemother; 2013 Dec; 57(12):5940-5. PubMed ID: 24041897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phosphate Promotes the Recovery of Mycobacterium tuberculosis β-Lactamase from Clavulanic Acid Inhibition.
    Elings W; Tassoni R; van der Schoot SA; Luu W; Kynast JP; Dai L; Blok AJ; Timmer M; Florea BI; Pannu NS; Ubbink M
    Biochemistry; 2017 Nov; 56(47):6257-6267. PubMed ID: 29087696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and Structural Characterization of the Interaction of 6-Methylidene Penem 2 with the β-Lactamase from Mycobacterium tuberculosis.
    Hazra S; Kurz SG; Wolff K; Nguyen L; Bonomo RA; Blanchard JS
    Biochemistry; 2015 Sep; 54(36):5657-64. PubMed ID: 26237118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains.
    Higgins PG; Wisplinghoff H; Stefanik D; Seifert H
    Antimicrob Agents Chemother; 2004 May; 48(5):1586-92. PubMed ID: 15105109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.